OpenVSafe by OpenVAERS
Search V-safe

3B2-20043-44560

2 vaccinations 15 coded responses 25 check-ins 15 free-text entries 6 call cases
Sex
—
Age at first dose
31-35
ZIP prefix
984 / WA
Registered
2021-03-31
Relationship
Self
Race
White
Ethnicity
Not Hispanic or Latino

Timeline

  1. 2021-03-31
    Registered in v-safe
  2. 2021-03-31
    Dose 1 — Moderna
  3. 2021-03-31
    Health check-in — day 0, dose 1
    Feeling: Fair · Headache, Muscle or body aches, Fatigue or tiredness, Abdominal pain
    Adult check-in
  4. 2021-04-01
    Survey response — days 1–6 daily, dose 1
    MedDRA: Ear pain — Feeling: Poor · Site: Pain · Muscle or body aches, Fatigue or tiredness, Abdominal pain · Be unable to work, Be unable to do your normal daily activities
    Free text: Transient ear pain
    MedDRA releases: 2021-09,2023-04,2024-11 · check-in free text available
  5. 2021-04-02
    Survey response — days 1–6 daily, dose 1
    MedDRA: Erythema, Insomnia, Nasal dryness — Feeling: Poor · Site: Pain, Swelling · Fever · Muscle or body aches, Fatigue or tiredness, Rash, not including the immediate area around the injection site · Be unable to do your normal daily activities, Get care from a doctor or other healthcare professional · Telehealth, virtual health, or email health consultation
    Free text: Reddness in my left nostril, dry feeling. Visual optical illusion disturbances related to digital screens flowing like a curtain or drifting. Underwater feeling. Increased talking and agitation. Trouble sleeping.
    MedDRA releases: 2021-09,2023-04,2024-11 · check-in free text available
  6. 2021-04-02
    Report sent to call center — days 1–6 daily, dose 1
    Be unable to do your normal daily activities · Get care from a doctor or other healthcare professional
    1 call case(s)
  7. 2021-04-03
    Survey response — days 1–6 daily, dose 1
    MedDRA: Dizziness, Rash, Visual impairment — Feeling: Fair · Site: Pain · Fatigue or tiredness, Diarrhea, Rash, not including the immediate area around the injection site
    Free text: Rash in left nostril, Wooziness, Vision Blurring upon waking, Dizziness
    MedDRA releases: 2021-09,2023-04,2024-11 · check-in free text available
  8. 2021-04-04
    Survey response — days 1–6 daily, dose 1
    MedDRA: Erythema, Nasal mucosal disorder, Sneezing, Vision blurred — Feeling: Fair · Be unable to do your normal daily activities
    Free text: Increased Vision Blurring, Sneezing, Red inside left nostril
    MedDRA releases: 2021-09,2023-04,2024-11 · check-in free text available
  9. 2021-04-05
    Survey response — days 1–6 daily, dose 1
    MedDRA: Vision blurred — Feeling: Fair · Site: Pain · Fatigue or tiredness · Be unable to do your normal daily activities
    Free text: Vision blurring when turning head too quickly
    MedDRA releases: 2021-09,2023-04,2024-11 · check-in free text available
  10. 2021-04-06
    Survey response — days 1–6 daily, dose 1
    MedDRA: Dizziness — Feeling: Fair · Muscle or body aches, Fatigue or tiredness · Be unable to do your normal daily activities
    Free text: Dizziness
    MedDRA releases: 2021-09,2023-04,2024-11 · check-in free text available
  11. 2021-04-07
    Survey response — day 7, dose 1
    MedDRA: Dizziness — Feeling: Fair · Muscle or body aches, Fatigue or tiredness · Be unable to do your normal daily activities
    Free text: Wooziness
    MedDRA releases: 2021-09,2023-04,2024-11 · check-in free text available
  12. 2021-04-14
    Survey response — day 14, dose 1
    MedDRA: Dizziness — Feeling: Poor · Get care from a doctor or other healthcare professional · Telehealth, virtual health, or email health consultation
    Free text: Wooziness, dizziness
    MedDRA releases: 2021-09,2023-04,2024-11 · check-in free text available
  13. 2021-04-14
    Report sent to call center — day 14, dose 1
    Get care from a doctor or other healthcare professional
    1 call case(s)
  14. 2021-04-21
    Health check-in — day 21, dose 1
    Feeling: Fair
    Adult check-in
  15. 2021-04-28
    Dose 2 — Moderna
  16. 2021-04-28
    Survey response — day 0, dose 2
    MedDRA: Dizziness, Vision blurred — Feeling: Fair · Site: Pain, Swelling · Headache, Muscle or body aches · Be unable to do your normal daily activities
    Free text: Dizziness, Blurry Vision
    MedDRA releases: 2021-09,2023-04,2024-11 · check-in free text available
  17. 2021-04-29
    Survey response — days 1–6 daily, dose 2
    MedDRA: Vision blurred — Feeling: Poor · Site: Pain · Fever · Chills, Headache, Muscle or body aches, Fatigue or tiredness, Nausea, Abdominal pain · Be unable to work, Be unable to do your normal daily activities
    Free text: Vision Blurring
    MedDRA releases: 2021-09,2023-04,2024-11 · check-in free text available
  18. 2021-04-30
    Health check-in — days 1–6 daily, dose 2
    Feeling: Fair · Site: Pain · Fatigue or tiredness · Be unable to do your normal daily activities
    Adult check-in
  19. 2021-05-02
    Health check-in — days 1–6 daily, dose 2
    Feeling: Fair · Fatigue or tiredness · Be unable to do your normal daily activities
    Adult check-in
  20. 2021-05-03
    Health check-in — days 1–6 daily, dose 2
    Feeling: Fair · Fatigue or tiredness · Be unable to do your normal daily activities
    Adult check-in
  21. 2021-05-04
    Health check-in — days 1–6 daily, dose 2
    Feeling: Fair · Muscle or body aches, Fatigue or tiredness · Be unable to do your normal daily activities
    Adult check-in
  22. 2021-05-08
    Health check-in — day 7, dose 2
    Feeling: Fair · Fatigue or tiredness · Be unable to do your normal daily activities
    Adult check-in
  23. 2021-05-12
    Health check-in — day 14, dose 2
    Feeling: Fair
    Adult check-in
  24. 2021-05-21
    Health check-in — day 21, dose 2
    Feeling: Fair
    Adult check-in
  25. 2021-05-26
    Survey response — day 28, dose 2
    MedDRA: Headache, Pain in extremity, Paraesthesia — Feeling: Fair · Be unable to do your normal daily activities
    Free text: Tingling in feet, aches in legs, headache
    MedDRA releases: 2021-09,2023-04,2024-11 · check-in free text available
  26. 2021-06-02
    Survey response — day 35, dose 2
    MedDRA: Agitation, Depression — Feeling: Fair · Be unable to do your normal daily activities, Get care from a doctor or other healthcare professional · Telehealth, virtual health, or email health consultation
    Free text: Agitation increased, depression increased
    MedDRA releases: 2021-09,2023-04,2024-11 · check-in free text available
  27. 2021-06-02
    Report sent to call center — day 35, dose 2
    Be unable to do your normal daily activities · Get care from a doctor or other healthcare professional
    1 call case(s)
  28. 2021-06-09
    Survey response — day 42, dose 2
    MedDRA: Agitation, Depression, Injection site pain — Feeling: Fair · Be unable to do your normal daily activities, Get care from a doctor or other healthcare professional · Telehealth, virtual health, or email health consultation
    Free text: Sporadic deep pain in arm at injection site. Agitation, depression.
    MedDRA releases: 2021-09,2023-04,2024-11 · check-in free text available
  29. 2021-06-09
    Report sent to call center — day 42, dose 2
    Be unable to do your normal daily activities · Get care from a doctor or other healthcare professional
    1 call case(s)
  30. 2021-06-15
  31. 2021-06-15
  32. 2021-06-15
  33. 2021-06-15
  34. 2021-07-28
    Health check-in — 3 months, dose 2
    Feeling: Fair
    Adult check-in
  35. 2021-11-01
    Survey response — 6 months, dose 2
    MedDRA: Hypoaesthesia, Hypoaesthesia oral, Intranasal hypoaesthesia, Unevaluable event — Feeling: Fair · Get care from a doctor or other healthcare professional · Telehealth, virtual health, or email health consultation
    Free text: Symptoms: Facial, gum, and nostril numbness on right side of my face · Healthcare visit (other): Was recommended to seek Outpatient services for an MRI but hesitant due to COVID risk
    MedDRA releases: 2024-11 · check-in free text available
  36. 2021-11-01
    Report sent to call center — 6 months, dose 2
    Get care from a doctor or other healthcare professional
    Telehealth, virtual health, or email health consultation · 1 call case(s)
  37. 2021-11-03
  38. 2022-04-28
    Survey response — 12 months, dose 2
    MedDRA: Diplopia, Eye patch application, Vision blurred — Feeling: Fair · Be unable to work or attend school, Be unable to do your normal daily activities, Get care from a doctor or other healthcare professional · Telehealth, virtual health, or email health consultation
    Free text: Right eye seemed to have issues focusing. Got double vision requiring an eyepatch beginning ~3/14 and seemed to dissipate starting 4/8
    MedDRA releases: 2024-11 · check-in free text available
  39. 2022-04-28
    Report sent to call center — 12 months, dose 2
    Be unable to work or attend school · Be unable to do your normal daily activities · Get care from a doctor or other healthcare pr
    Telehealth, virtual health, or email health consultation · 1 call case(s)
  40. 2022-05-02

Vaccinations

DoseDateManufacturerCo-administered
12021-03-31Moderna
22021-04-28Moderna

Call center

6 call center cases

6 unsuccessful

See the call center timeline

Free text

Release 6 — days 1–6 daily, dose 1

2021-04-01

Systemic reaction (other): Transient ear pain

2021-04-02

Systemic reaction (other): Reddness in my left nostril, dry feeling. Visual optical illusion disturbances related to digital screens flowing like a curtain or drifting. Underwater feeling. Increased talking and agitation. Trouble sleeping.

2021-04-03

Systemic reaction (other): Rash in left nostril, Wooziness, Vision Blurring upon waking, Dizziness

2021-04-04

Systemic reaction (other): Increased Vision Blurring, Sneezing, Red inside left nostril

2021-04-05

Systemic reaction (other): Vision blurring when turning head too quickly

Release 7 — days 1–6 daily, dose 1

2021-04-06

Systemic reaction (other): Dizziness

Release 7 — day 7, dose 1

2021-04-07

Systemic reaction (other): Wooziness

Release 7 — day 14, dose 1

2021-04-14

Symptoms: Wooziness, dizziness

Release 8 — day 0, dose 2

2021-04-28

Systemic reaction (other): Dizziness, Blurry Vision

Release 8 — days 1–6 daily, dose 2

2021-04-29

Systemic reaction (other): Vision Blurring

Release 8 — day 28, dose 2

2021-05-26

Symptoms: Tingling in feet, aches in legs, headache

Release 8 — day 35, dose 2

2021-06-02

Symptoms: Agitation increased, depression increased

Release 9 — day 42, dose 2

2021-06-09

Symptoms: Sporadic deep pain in arm at injection site. Agitation, depression.

Release 10 — 6 months, dose 2

2021-11-01

Symptoms: Facial, gum, and nostril numbness on right side of my face
Healthcare visit (other): Was recommended to seek Outpatient services for an MRI but hesitant due to COVID risk

Release 11 — 12 months, dose 2

2022-04-28

Symptoms: Right eye seemed to have issues focusing. Got double vision requiring an eyepatch beginning ~3/14 and seemed to dissipate starting 4/8

Each entry is dated by the survey it was written in (the CDC re-sent the releases with survey dates in 2025); click a date to see that survey response. The CDC cut some text off at about 250 characters: symptoms in every release, and the other two fields in releases 9-12. Those entries are marked "cut off by CDC".

MedDRA terms by release

FieldPreferred term2021-092023-042024-11
HCVOUnevaluable event · · ✓
SDAgitation ✓ ✓ ✓
SDDepression ✓ ✓ ✓
SDDiplopia · · ✓
SDDizziness ✓ ✓ ✓
SDEye patch application · · ✓
SDHeadache ✓ ✓ ✓
SDHypoaesthesia · · ✓
SDHypoaesthesia oral · · ✓
SDInjection site pain ✓ ✓ ✓
SDIntranasal hypoaesthesia · · ✓
SDPain in extremity ✓ ✓ ✓
SDParaesthesia ✓ ✓ ✓
SDVision blurred · · ✓
SRODizziness ✓ ✓ ✓
SROEar pain ✓ ✓ ✓
SROErythema ✓ ✓ ✓
SROInsomnia ✓ ✓ ✓
SRONasal dryness ✓ ✓ ✓
SRONasal mucosal disorder ○ ✓ ✓
SRORash ✓ ✓ ✓
SROSneezing ✓ ✓ ✓
SROVision blurred ✓ ✓ ✓
SROVisual impairment ✓ ✓ ✓

✓ active code · ○ coded but marked inactive · blank = not in that release